Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3060
+0.0042 (1.39%)
Oct 30, 2026, 8:57 AM EDT - Market open
Mereo BioPharma Group Employees
Mereo BioPharma Group had 39 employees as of December 31, 2025. The number of employees increased by 3 or 8.33% compared to the previous year.
Employees
39
Change (1Y)
3
Growth (1Y)
8.33%
Revenue / Employee
n/a
Profits / Employee
-$720,487
Market Cap
48.87M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 39 | 3 | 8.33% |
| Dec 31, 2024 | 36 | 3 | 9.09% |
| Dec 31, 2023 | 33 | -3 | -8.33% |
| Dec 31, 2022 | 36 | -13 | -26.53% |
| Dec 31, 2021 | 49 | 11 | 28.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caribou Biosciences | 97 |
| Biomea Fusion | 37 |
| Elicio Therapeutics | 33 |
| Actinium Pharmaceuticals | 27 |
| iBio, Inc. | 23 |
| LeonaBio | 19 |
| ImageneBio | 18 |
| Apollomics | 14 |
MREO News
- 2 months ago - JPMorgan downgrades Mereo to Underweight on regulatory uncertainty - TheFly
- 2 months ago - Mereo BioPharma downgraded to Underweight from Neutral at JPMorgan - TheFly
- 2 months ago - Mereo BioPharma Advances Alvelestat Partnership; Cash Runway Extended Into Late 2027 - Nasdaq
- 2 months ago - Mereo BioPharma Group Releases Q2 2026 Financial Results - AlphaStreet
- 2 months ago - Mereo BioPharma Licenses Alvelestat Rights To Sentynl Therapeutics - Nasdaq
- 2 months ago - Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights - GlobeNewsWire
- 2 months ago - Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) - PRNewsWire
- 5 months ago - 4basebio Announces Appointment of Chief Financial Officer and Board Changes - GlobeNewsWire